Baroda BNP Paribas Health and Wellness Fund - Growth - Regular Plan

Other Plans and Options
  • 0.48 %Nav, as on 17-02-2026

  • Previous Nav

  • Net Change on 17-02-2026

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 8.95 22.47 14.59 1.83 7,875.40
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 6.69 26.12 16.42 1.86 6,658.41
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 6.05 24.11 15.54 1.94 3,822.73
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 -3.30 19.61 13.45 1.94 2,971.07
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 6.15 21.91 14.28 2.14 1,239.57

Fund Holdings as on 31-January-2026

  • Sun Pharmaceutical Industries Limited

  • Mankind Pharma Limited

  • Cipla Limited

  • Max Healthcare Institute Limited

  • Abbott India Limited

  • Lupin Limited

  • Torrent Pharmaceuticals Limited

  • Aster DM Healthcare Limited

  • AstraZeneca Pharma India Limited

  • IPCA Laboratories Limited

  • Apollo Hospitals Enterprise Limited

  • JB Chemicals & Pharmaceuticals Limited

  • ICICI Prudential Life Insurance Company Limited

  • Gland Pharma Limited

  • Fortis Healthcare Limited

  • Rainbow Childrens Medicare Limited

  • Laurus Labs Limited

  • Ajanta Pharma Limited

  • Emcure Pharmaceuticals Limited

  • Dr. Lal Path Labs Limited

  • Dr. Reddy's Laboratories Limited

  • Clearing Corporation of India Ltd

  • MedPlus Health Services Limited

  • Divi's Laboratories Limited

  • Inventurus Knowledge Solutions Limited

  • Jupiter Life Line Hospitals Limited

  • Net Receivables / (Payables)

  • Metropolis Healthcare Limited

  • Nephrocare Health Services Ltd

  • SBI Life Insurance Company Limited

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Insurance

  • Miscellaneous

  • Retailing

  • BPO/ITeS

View More

  • Cash

  • Equity

View More

About Baroda BNP Paribas Health and Wellness Fund

Scheme Analysis

Baroda BNP Paribas Health and Wellness Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Baroda BNP Paribas Mutual Fund. It was launched on 27-Jun-2025 and currently has an AUM of ₹544.81 crore. Baroda BNP Paribas Health and Wellness Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of Baroda BNP Paribas Health and Wellness Fund ended up ₹0.05(0.48%)yesterday to ₹9.4522.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The Baroda BNP Paribas Health and Wellness Fund is managed by Sanjay Chawla .

Fund House Contact

201(A) 2nd Floor, A wing, Crescenzo, C-38 & 39, G-Block, Bandra Kurla Complex, Mumbai - 400051

91-22-3370 4000
91-22-3370 4294